Pdl Biopharma Stock Filter Stocks by Fundamentals
PDL BioPharma fundamentals help investors to digest information that contributes to PDL BioPharma's financial success or failures. It also enables traders to predict the movement of PDL Stock. The fundamental analysis module provides a way to measure PDL BioPharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PDL BioPharma stock.
PDL |
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
PDL Fundamentals
| Return On Equity | -7.36 | |||
| Return On Asset | -4.1 | |||
| Operating Margin | (166.77) % | |||
| Current Valuation | 213.07 M | |||
| Shares Outstanding | 114.23 M | |||
| Shares Owned By Insiders | 2.27 % | |||
| Shares Owned By Institutions | 96.53 % | |||
| Number Of Shares Shorted | 11.87 M | |||
| Price To Earning | 526.67 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 11.03 X | |||
| Revenue | 27.76 M | |||
| Gross Profit | 13.43 M | |||
| EBITDA | (42.98 M) | |||
| Net Income | (39.18 M) | |||
| Cash And Equivalents | 105.45 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 13.51 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 13.68 X | |||
| Book Value Per Share | 3.69 X | |||
| Cash Flow From Operations | (56.35 M) | |||
| Short Ratio | 5.20 X | |||
| Earnings Per Share | (1.32) X | |||
| Price To Earnings To Growth | (0.35) X | |||
| Number Of Employees | 109 | |||
| Beta | 1.14 | |||
| Market Capitalization | 282.14 M | |||
| Total Asset | 1.01 B | |||
| Retained Earnings | 594.7 M | |||
| Working Capital | 245.97 M | |||
| Current Asset | 282.71 M | |||
| Current Liabilities | 36.74 M | |||
| Z Score | 12.0 | |||
| Five Year Return | 8.94 % | |||
| Last Dividend Paid | 0.05 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PDL BioPharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PDL BioPharma's short interest history, or implied volatility extrapolated from PDL BioPharma options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PDL BioPharma using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in PDL Stock
If you are still planning to invest in PDL BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PDL BioPharma's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |